As Google CEO Sundar Pichai fends off questions from Congress, plans are underway to shut down Google+ amid data privacy fears. Our poll with @IBM shows that 85% of consumers want companies to do more to protect their data. #GoogleHearing #dataprivacy
What is keeping you from saving for retirement? 44% of Americans say they don't make enough money to contribute to their retirement plan, according to our survey with @NWFinancial. #retirement #retirementsavings #nationwide
The tech giant drew the public's ire when it was discovered that it had failed to disclose the data breach last spring for fear of damaging its reputation.
Google's CEO Sundar Pichai is slated to address Congress today, December 11, where he'll most likely fend off questions from lawmakers regarding consumer privacy, Google's relationship with China, regulation of the tech industry and allegations of political bias.
These scandals could impact Google's already tumbling reputation as the company's corporate reputation dropped from #8 in 2017 to #28 in the 2018 Harris Poll Reputation Quotient study. Google will have to do more to assuage the fears of a public that is already wary of their personal information getting leaked. Our recent survey for IBM uncovered deepening consumer anxiety over data privacy and security. 85% of consumers said businesses should be doing more to actively protect their data and 75% will not buy a product from a company – no matter how great the products are – if they don't trust the company to protect their data.
Americans voters from across the political spectrum seem to desire stronger American leadership on key human rights issues, according to our 2015 survey for Human Rights First. Most Americans say eliminating hate crimes (59%) and human trafficking (56%) worldwide are among the most important issues. The poll found that more than three in four Americans believe that the U.S. should lead the world in promoting human rights.
But it's not just political leadership that Americans want, they are turning to corporations to champion human rights and practice their values in their business processes. The Human Rights First study also found that 82% of Americans want companies to be held accountable for slavery and human trafficking when it occurs in their supply chains. And our recent survey with Out & Equal Workplace Associates revealed that more than 80% of Americans say businesses should not be able to deny service based on race, ethnicity, national origin, sex, sexual orientation, gender identity, religion or disability.
The UDHR is a foundational document of international human rights law and was referred to as humanity’s Magna Carta by Eleanor Roosevelt, who chaired the UN's Commission on Human Rights that was responsible for the drafting of the document.
Medical science has made tremendous advances in "personalized medicine" -- drugs that fight cancer and other diseases by boosting the immune system or targeting specific genetic traits.
Former U.S. President Jimmy Carter benefited from one of these drugs, Keytruda (pembrolizumab), which successfully beat back his brain cancer by ramping up his immune system.
But the American public is still struggling to understand the implications of these new targeted treatments, a new HealthDay/Harris Poll has found.
A large majority (71%) of Americans are unfamiliar with personalized medicine, the survey found.
Among those who are familiar with the concept, nearly half (49%) don't understand that this new type of therapy is typically more successful, with fewer side effects, compared to other treatments.
On the other hand, most (62%) didn't realize that the cost of the drugs will be significantly higher than other treatments.
The online survey of over 2,000 adults was conducted Nov. 15-19.
"Very few Americans know a lot about personalized medicine but, nevertheless, people are excited about it, particularly regarding its potential to save lives and revolutionize health care," said Deana Percassi, managing director of The Harris Poll's public relations research practice.
Personalized medicine, also called precision medicine, uses genetic profiling and specific knowledge of a person's body to optimize therapies.
For example, there's a drug called Lynparza (olaparib) that treats people with advanced breast and ovarian cancers caused by mutations of the BRCA gene. The drug blocks an enzyme and makes it more likely for cancerous cells to die off more quickly.
In an advance for the field, last week the U.S. Food and Drug Administration approved a drug for a treatment of a wide range of cancers based on a shared mutation. The drug, Vitrakvi (larotrectinib), can treat thyroid, lung, and head and neck cancers caused by a common genetic factor.
Read more at HealthDay.
In a new study the Harris Poll conducted for CareDox and Families Fighting Flu, we found that a majority of Americans (85%) understand that otherwise healthy children can die from the flu, yet nearly half of parents of kids under 18 have still not had their children vaccinated and 17% of parents don't plan to get their children vaccinated this flu season.
According to the CDC, 2017 was the worst flu season on record, with an estimated 79,000 deaths, including 185 children. Approximately 80% of these deaths occurred in children who had not received a flu vaccination that season. This year's flu season is already underway, and there have already been two reported pediatric flu deaths.
The survey found that parents weren't vaccinating their children because they don't believe the flu vaccine works (55%), they think the vaccine isn't safe (52%) and some even believe they can get the flu from the vaccine (32%)
"Parents may believe that children, even healthy children, dying from flu is a rare occurrence," said Serese Marotta, chief operating officer of Families Fighting Flu, in a press release. "But the members of our organization, including myself, can tell you that flu hospitalizations and deaths occur much more frequently than we'd like to think. And we want parents to know that annual flu vaccination is the best defense we have against influenza."
Families Fighting Flu and CareDox are collaborating to combat the myths surrounding flu and the flu vaccination, with the aim of increasing flu vaccination rates for school-age children this season. Families Fighting Flu will provide flu facts as well as stories of families that have been adversely impacted by this disease to raise awareness about the dangers of flu while CareDox will make it easy for parents to locate and sign up for no-cost school-located vaccine clinics in their areas through its website.
Microsoft announced that it will add real-time captions and subtitles to PowerPoint early next year to break down communication barriers and help presenters interact effectively with their audiences.
The AI-powered feature was conceived in honor of the United Nations International Day of Persons with Disabilities, an annual day of observance, on December 3, that raises awareness on issues faced by people with disabilities around the world.
"Live captions & subtitles in PowerPoint supports the deaf and hard of hearing community by giving them the ability to read what is being spoken in real-time," Microsoft said of the feature in a blog post. "In addition, captions and subtitles can be displayed in the same language or in a different one, allowing non-native speakers to get a translation of a presentation."
The captions are based on Microsoft’s ongoing AI work, and, according to The Verge, the company has used similar software for its own presentations. "Presenters will be able to customize the appearance of subtitles to match a presentation, and the speech recognition should adapt for more accurate terminology based on context."
Microsoft is planning to bring these features to the Office 365 version of PowerPoint in late January 2019 across Windows, PowerPoint for Mac, and online versions of PowerPoint. The new tool will support 12 spoken languages and display on-screen in more than 60 different languages.
PowerPoint's new perk could bode well for Microsoft's reputation as a recent Harris Poll survey on consumer perceptions of companies shows Microsoft faring better than its tech peers, Apple and Google, on certain aspects of financial performance. In the Harris Poll's 2018 Reputation Quotient study, consumers ranked Microsoft (60%) higher than Apple (55%) and Google (53%) when asked which company had strong prospects for future growth.